BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22711178)

  • 1. Lumican and versican are associated with good outcome in stage II and III colon cancer.
    de Wit M; Belt EJ; Delis-van Diemen PM; Carvalho B; Coupé VM; Stockmann HB; Bril H; Beliën JA; Fijneman RJ; Meijer GA
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S348-59. PubMed ID: 22711178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
    de Wit M; Carvalho B; Delis-van Diemen PM; van Alphen C; Beliën JAM; Meijer GA; Fijneman RJA
    PLoS One; 2017; 12(5):e0174768. PubMed ID: 28481899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of stromal versican expression in human endometrial cancer.
    Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
    Ann Oncol; 2007 Feb; 18(2):269-74. PubMed ID: 17065588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle proteins predict recurrence in stage II and III colon cancer.
    Belt EJ; Brosens RP; Delis-van Diemen PM; Bril H; Tijssen M; van Essen DF; Heymans MW; Beliën JA; Stockmann HB; Meijer S; Meijer GA
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S682-92. PubMed ID: 22311118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
    Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
    Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
    Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.
    Chida S; Okayama H; Noda M; Saito K; Nakajima T; Aoto K; Hayase S; Momma T; Ohki S; Kono K; Takenoshita S
    Carcinogenesis; 2016 Sep; 37(9):878-887. PubMed ID: 27287872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical composition of the human lunotriquetral interosseous ligament.
    Chatuparisute P; Shinohara Y; Kirchhoff C; Fischer F; Milz S
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):318-24. PubMed ID: 22505013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumican is overexpressed in lung adenocarcinoma pleural effusions.
    Cappellesso R; Millioni R; Arrigoni G; Simonato F; Caroccia B; Iori E; Guzzardo V; Ventura L; Tessari P; Fassina A
    PLoS One; 2015; 10(5):e0126458. PubMed ID: 25961303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
    Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
    Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence.
    Belt EJ; Fijneman RJ; van den Berg EG; Bril H; Delis-van Diemen PM; Tijssen M; van Essen HF; de Lange-de Klerk ES; Beliën JA; Stockmann HB; Meijer S; Meijer GA
    Eur J Cancer; 2011 Aug; 47(12):1837-45. PubMed ID: 21621406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
    Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
    Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versican expression in tumor epithelial cells is correlated with a good prognosis in gastric cancer.
    Kim NS; Lee HH; Jung CK; Jeon HM
    Anticancer Res; 2014 Oct; 34(10):5613-9. PubMed ID: 25275064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy.
    Turksma AW; Coupé VM; Shamier MC; Lam KL; de Weger VA; Belien JA; van den Eertwegh AJ; Meijer GA; Meijer CJ; Hooijberg E
    Clin Cancer Res; 2016 Jan; 22(2):346-56. PubMed ID: 26420855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
    Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
    J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CXCR4 and CD133 co-expression on the prognosis of patients with stage II~III colon cancer.
    Li XF; Guo XG; Yang YY; Liu AY
    Asian Pac J Cancer Prev; 2015; 16(3):1073-6. PubMed ID: 25735334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis.
    Voutilainen K; Anttila M; Sillanpää S; Tammi R; Tammi M; Saarikoski S; Kosma VM
    Int J Cancer; 2003 Nov; 107(3):359-64. PubMed ID: 14506734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.
    El-Gendi SM; Mostafa MF; El-Gendi AM
    Pathol Oncol Res; 2012 Apr; 18(2):459-69. PubMed ID: 22057638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.